MedPath

Idorsia Ltd

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
$464M
Website
http://www.idorsia.com
finance.yahoo.com
·

Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?

Viatris' Q4 2023 earnings missed estimates with 61 cents per share and $3.8 billion in revenues, down 1% year-over-year. Despite a 14% sales increase in Emerging Markets, overall performance was mixed. The company paid down $500 million in debt and entered a R&D collaboration with Idorsia Ltd. for two phase III assets. 2024 revenue is projected between $15.25-$15.75 billion, with EPS expected at $2.70-$2.85.
© Copyright 2025. All Rights Reserved by MedPath